Jan. 14, 2025 – The U.S. Preventive Services Task Force has published a final recommendation statement on screening for osteoporosis to prevent fractures.
Jan. 10, 2024 — ImagingU has announced the dates of its 2025 MRI Safety and MRSO Conferences.
ImagingU’s in-person weekend conferences are designed for current or aspiring MR Safety Officers, as well as other radiology professionals looking to increase their MRI safety knowledge or earn continuing education credits (CEUs).
Jan. 13, 2025 -- ERS Genomics, the CRISPR licensing company, has announced the launch of its Express License platform to provide small research enterprises and startups with affordable and rapid access to the world’s largest foundational and essential CRISPR/Cas9 patent portfolio.
Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research, development and implementation of quantitative imaging biomarkers. After a decade of close collaboration as separate entities on image based risk assessment, this deal is expected to bring breast cancer risk assessment capabilities to ScreenPoint's Breast AI, Transpara.
Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of pancreatic tumors.
Computed tomography (CT) has long been a cornerstone of modern imaging, providing detailed 3D insights into the human body and other materials. However, conventional CT requires hundreds of X-ray projections from multiple angles, exposing patients to significant radiation doses and relying on large, immobile systems.
Dec. 13, 2024 — A recent study by the Harvey L. Neiman Health Policy Institute demonstrates that mobile mammography is generally used by women otherwise unlikely to be screened, and thus is complementary to facility-based mammography rather than a substitute for it. Hence, mobile mammography could feasibly increase breast cancer screening rates, especially in traditionally underserved communities.
Dec. 18, 2024 – Accuray Inc. recently announced an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife System, can provide an effective and time-saving treatment option for brainstem metastases (BSM). The nine institution study results, published in the International Journal of Cancer, “underscore the long- term benefits in local control and the robust safety profile despite the delicate location of the treated metastases.1”
Dec. 12, 2024 — RIVANNA has released a report that details significant regional demand for anesthesiologists while also examining the rapid growth of the diagnostic ultrasound market, a development influenced by technological advancements and evolving healthcare needs.
